Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Liying Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-7293-2909; OpenAlex author ID A5100405017. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 6

  1. Retraction Note: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Co-author DOI 10.1186/s12935-025-03710-4↗
  2. Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2021.121176↗
  3. Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapy. First author DOI 10.1039/d0nr03138k↗
  4. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Co-author DOI 10.1186/s12935-020-01288-7↗
  5. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. Co-author DOI 10.1002/iub.1699↗
  6. Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance. Co-author DOI 10.1016/j.biomaterials.2017.08.002↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyuan Hua · 3 shared papers, 2018–2025 · strength 0.47
  2. Yongping Zhou · 3 shared papers, 2018–2025 · strength 0.47
  3. Tu Dai · 2 shared papers, 2020–2025 · strength 0.39
  4. Quan Zhou · 2 shared papers, 2017–2021 · strength 0.18
  5. Youqing Shen · 2 shared papers, 2017–2021 · strength 0.18
  6. Xiangrui Liu · 2 shared papers, 2017–2021 · strength 0.18
  7. Fang‐Ming Chen · 1 shared paper, 2020 · strength 0.12
  8. Xiangsheng Liu · 1 shared paper, 2021 · strength 0.12
  9. Haiping Jiang · 1 shared paper, 2021 · strength 0.12
  10. Liping Cao · 1 shared paper, 2021 · strength 0.12
  11. Huan Meng · 1 shared paper, 2021 · strength 0.12
  12. Jie‐Qin Wang · 1 shared paper, 2020 · strength 0.10
  13. Chen‐Song Huang · 1 shared paper, 2020 · strength 0.10
  14. Xiaoyu Yin · 1 shared paper, 2020 · strength 0.10
  15. Xi‐Tai Huang · 1 shared paper, 2020 · strength 0.10
  16. Tu Dai · 1 shared paper, 2018 · strength 0.09
  17. Haixin Qian · 1 shared paper, 2018 · strength 0.09
  18. Zipeng Lu · 1 shared paper, 2017 · strength 0.06
  19. Yi Miao · 1 shared paper, 2017 · strength 0.06
  20. Weilin Wang · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.